Contact Us

DESTINATION NEWS

GCCAC advances cooperation with BRI partners

Dec 10, 2024

FUZHOU,China,Dec. 7,2024-- The 2024 Belt and Road Commerce Chambers and Associations Conference (GCCAC) was held in Fuzhou,East China\'s Fujian Province on Thursday.

NYXI Unveils the NYXI Flexi Game Controller: A New Era of Customizable Button Layouts

Dec 10, 2024

HONG KONG,Dec. 7,2024--Today,NYXI officially announces the global launch of the NYXI Flexi Wireless Game Controller,designed to deliver a seamless and customizable gaming experience across multiple pl

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

Dec 10, 2024

SHANGHAI,Dec. 9,2024-- December 8,2024,Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versu

Global Total Semiconductor Equipment Sales Forecast to Reach a Record of $139 Billion in 2026, SEMI Reports

Dec 10, 2024

Front-end and Back-end Segments Projected to Support Consecutive Growth from 2024 through 2026 TOKYO,Dec. 9,2024--Global sales of total semiconductor manufacturing equipment by original equipment man

CIFM / interzum guangzhou 2025: Asia's premier furniture manufacturing event returns to shape the future

Dec 10, 2024

GUANGZHOU,China,Dec. 9,2024-- As the beating hub of Asia\'s furniture manufacturing industry,CIFM / interzum guangzhou 2025,organised by Koelnmesse and China Foreign Trade Centre Group,Ltd.,is set to

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

Dec 10, 2024

BEIJING,SHANGHAI and BOSTON,Dec. 9,2024-- Jacobio Pharma (1167.HK),a clinical-stage oncology company dedicated to developing therapies toward undruggable targets,today presented preliminary Phase I da

1 ... 176 177 178 179 180 181 182 ... 351